Vicapsys Life Sciences, Inc. (VICP)
OTCMKTS · Delayed Price · Currency is USD
1.500
0.00 (0.00%)
At close: Oct 23, 2025
Vicapsys Life Sciences Market Cap
Vicapsys Life Sciences has a market cap or net worth of $48.56 million as of November 3, 2025.
Market Cap
48.56M
Enterprise Value
49.05M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.50
Market Cap Chart
Since January 5, 2018, Vicapsys Life Sciences's market cap has increased from 9.76M to 48.56M, an increase of 397.51%. That is a compound annual growth rate of 22.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2025 | 48.56M | 151,740,365.63% |
| Dec 10, 2024 | 32.00 | -100.00% |
| Dec 20, 2023 | 87.88M | 1,045.91% |
| Dec 18, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 660.18M |
| Glass House Brands | 569.74M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 338.20M |
| Nika Pharmaceuticals | 312.10M |
| American Oncology Network | 305.06M |
| CytoDyn | 302.34M |